Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,821 | -64,920 | -63,173 | -35,740 | -9,612 |
| Depreciation Amortization | 1,056 | 17,661 | 15,948 | 15,794 | 4,263 |
| Income taxes - deferred | 9 | -194 | -180 | 267 | 83 |
| Accounts receivable | -15,439 | 7,108 | N/A | 3,875 | 3,817 |
| Accounts payable and accrued liabilities | 955 | -134 | 515 | -1,004 | -2,246 |
| Other Working Capital | -12,800 | -7,463 | -852 | -1,736 | -1,763 |
| Other Operating Activity | 19,764 | -6,790 | 17,405 | 4,136 | -6,028 |
| Operating Cash Flow | $-13,276 | $-54,732 | $-30,337 | $-14,408 | $-11,486 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 10 | -1,782 | -1,617 | -1,373 | -419 |
| Net Acquisitions | N/A | 90 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 118,145 | 118,145 | 7,300 | 7,300 |
| Investing Cash Flow | $10 | $116,453 | $116,528 | $5,927 | $6,881 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 55,112 | N/A | N/A | N/A |
| Debt Repayment | -899 | -222,306 | -35 | -5,327 | -16 |
| Common Stock Issued | 119 | 32,647 | 36 | 139 | 138 |
| Common Stock Repurchased | N/A | N/A | 234 | N/A | N/A |
| Other Financing Activity | -57 | -783 | -192,127 | -607 | -358 |
| Financing Cash Flow | $-837 | $-135,330 | $-191,892 | $-5,795 | $-236 |
| Beginning Cash Position | 40,444 | 114,053 | 114,053 | 114,053 | 114,053 |
| End Cash Position | 26,341 | 40,444 | 8,352 | 99,777 | 109,212 |
| Net Cash Flow | $-14,103 | $-73,609 | $-105,701 | $-14,276 | $-4,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,276 | -54,732 | -30,337 | -14,408 | -11,486 |
| Capital Expenditure | -27 | -1,782 | -1,657 | -1,398 | -422 |
| Free Cash Flow | -13,303 | -56,514 | -31,994 | -15,806 | -11,908 |